论文部分内容阅读
浙江医大一院1972年7月至1979年9月,用免疗及化疗作为诱导治疗,治疗急性白血病221例,其中急淋64例,急性非淋巴白血病157例(急粒115例,急单及粒单33例,早幼粒白血病3例,红白血病5例,急性组织细胞白血病1例),年龄11～59岁。急淋化疗以VMP方案为主,急性非淋巴白血病化疗用VACP、VCCP、VMMP、VAT、VCT等方案。部分病人同时加用以下3种非特异性自动免疫治疗方法之一:①新鲜液体结核菌苗(上海生物制品厂产),
Zhejiang Medical University Hospital from July 1972 to September 1979, with the treatment and chemotherapy as induction therapy, the treatment of acute leukemia in 221 cases, of which 64 cases of acute lymphoblastic acute leukemia in 157 cases (115 cases of emergency tablets, urgent orders and 33 cases of single grain, 3 cases of promyelocytic leukemia, 5 cases of erythroleukemia, 1 case of acute histiocytic leukemia), aged from 11 to 59 years old. Acute leaching chemotherapy to VMP program based, acute non-lymphoid leukemia chemotherapy with VACP, VCCP, VMMP, VAT, VCT and other programs. Some patients also add the following three kinds of non-specific automated immunotherapy methods: ① fresh liquid TB vaccine (Shanghai Biological Products Factory),